Listar por autor "Miyamoto, Samira Tatiyama"
Mostrando ítems 1-7 de 7
-
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana Project
Valim, Valéria et al. | Fecha del documento: 2022 -
Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study
Valim, Valéria et al. | Fecha del documento: 2020 -
Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis
Casagrande, Thays Zanon et al. | Fecha del documento: 2022 -
Safety and efficacy of primary yellow fever vaccination in autoimmune disease: a prospective controlled study
Valim, Valeria et al. | Fecha del documento: 2019 -
Safety of Coronavac and ChAdOx1 Vaccines Against SARS-CoV-2 in Patients with Rheumatoid Arthritis Data from the Brazilian Multicentric Study Safer.
Cruz, Vitor Alves et al. | Fecha del documento: 2023 -
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination
Rocha, Ismael Artur da Costa et al. | Fecha del documento: 2021 -
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose.
Gouvea, Maria da Penha Gomes et al. | Fecha del documento: 2023